136 related articles for article (PubMed ID: 16782353)
1. Effect of alkyl groups on the cellular hydrolysis of stavudine phosphoramidates.
Venkatachalam TK; Sarquis M; Qazi S; Uckun FM
Bioorg Med Chem; 2006 Sep; 14(18):6420-33. PubMed ID: 16782353
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and metabolism of naphthyl substituted phosphoramidate derivatives of stavudine.
Venkatachalam TK; Qazi S; Uckun FM
Bioorg Med Chem; 2006 Aug; 14(15):5161-77. PubMed ID: 16697204
[TBL] [Abstract][Full Text] [Related]
3. Lipase-mediated stereoselective hydrolysis of stampidine and other phosphoramidate derivatives of stavudine.
Venkatachalam TK; Samuel P; Li G; Qazi S; Mao C; Pendergrass S; Uckun FM
Bioorg Med Chem; 2004 Jun; 12(12):3371-81. PubMed ID: 15158806
[TBL] [Abstract][Full Text] [Related]
4. Protease-mediated enzymatic hydrolysis and activation of aryl phosphoramidate derivatives of stavudine.
Venkatachalam TK; Samuel P; Qazi S; Uckun FM
Eur J Med Chem; 2005 May; 40(5):452-66. PubMed ID: 15893019
[TBL] [Abstract][Full Text] [Related]
5. Stereochemical influence on lipase-mediated hydrolysis and biological activity of stampidine and other stavudine phosphoramidates.
Venkatachalam TK; Samuel P; Uckun FM
Bioorg Med Chem; 2005 Mar; 13(5):1763-73. PubMed ID: 15698793
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic hydrolysis of stampidine and other stavudine phosphoramidates in the presence of mammalian proteases.
Venkatachalam TK; Samuel P; Uckun FM
Bioorg Med Chem; 2005 Apr; 13(7):2651-5. PubMed ID: 15755664
[TBL] [Abstract][Full Text] [Related]
7. Effect of change in nucleoside structure on the activation and antiviral activity of phosphoramidate derivatives.
Venkatachalam TK; Samuel P; Qazi S; Uckun FM
Bioorg Med Chem; 2005 Sep; 13(18):5408-23. PubMed ID: 15994083
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the hydrolysis pathways of substituted aryl phosphoramidate versus aryl thiophosphoramidate derivatives of stavudine.
Venkatachalam TK; Yu G; Samuel P; Qazi S; Pendergrass S; Uckun FM
Eur J Med Chem; 2004 Aug; 39(8):665-83. PubMed ID: 15276300
[TBL] [Abstract][Full Text] [Related]
9. Novel phosphoramidates with porphine and nitrogenous drug: one-pot synthesis and orientation to cancer cells.
Wang ZW; Guo CC; Xie WZ; Liu CZ; Xiao CG; Tan Z
Eur J Med Chem; 2010 Mar; 45(3):890-5. PubMed ID: 19942325
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of LNA phosphoramidates.
Jensen J; Sjøgren G; Hansen JB; Rosenbohm C; Koch T
Nucleosides Nucleotides Nucleic Acids; 2008 Jan; 27(1):37-42. PubMed ID: 18188768
[TBL] [Abstract][Full Text] [Related]
11. Phosphoramidate and phosphate prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine: synthesis, anti-HIV activity and stability studies.
Liang Y; Narayanasamy J; Schinazi RF; Chu CK
Bioorg Med Chem; 2006 Apr; 14(7):2178-89. PubMed ID: 16314108
[TBL] [Abstract][Full Text] [Related]
12. Site-specific enzymatic activation of the anti-HIV agent stampidine.
Venkatachalam TK; Qazi S; Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):167-75. PubMed ID: 16570825
[TBL] [Abstract][Full Text] [Related]
13. Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins.
Chou TF; Baraniak J; Kaczmarek R; Zhou X; Cheng J; Ghosh B; Wagner CR
Mol Pharm; 2007; 4(2):208-17. PubMed ID: 17217311
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR.
Siddiqui AQ; McGuigan C; Ballatore C; Zuccotto F; Gilbert IH; De Clercq E; Balzarini J
J Med Chem; 1999 Oct; 42(20):4122-8. PubMed ID: 10514282
[TBL] [Abstract][Full Text] [Related]
15. Phosphoramidate derivatives of stavudine as inhibitors of HIV: unnatural amino acids may substitute for alanine.
McGuigan C; Bidois L; Hiouni A; Ballatore C; De Clercq E; Balzarini J
Antivir Chem Chemother; 2000 Mar; 11(2):111-6. PubMed ID: 10819435
[TBL] [Abstract][Full Text] [Related]
16. A novel synthesis of antiviral nucleoside phosphoramidate and thiophosphoramidate prodrugs via nucleoside H-phosphonamidates.
Sun Q; Li X; Gong S; Liu G; Shen L; Peng L
Nucleosides Nucleotides Nucleic Acids; 2013; 32(11):617-38. PubMed ID: 24138500
[TBL] [Abstract][Full Text] [Related]
17. Stereospecific chemical and enzymatic stability of phosphoramidate triester prodrugs of d4T in vitro.
Siccardi D; Gumbleton M; Omidi Y; McGuigan C
Eur J Pharm Sci; 2004 May; 22(1):25-31. PubMed ID: 15113580
[TBL] [Abstract][Full Text] [Related]
18. The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: synthesis, cytostatic and antiviral activity evaluations.
Wittine K; Benci K; Rajić Z; Zorc B; Kralj M; Marjanović M; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M
Eur J Med Chem; 2009 Jan; 44(1):143-51. PubMed ID: 18485540
[TBL] [Abstract][Full Text] [Related]
19. Telomerase inhibitors--oligonucleotide phosphoramidates as potential therapeutic agents.
Gryaznov S; Pongracz K; Matray T; Schultz R; Pruzan R; Aimi J; Chin A; Harley C; Shea-Herbert B; Shay J; Oshima Y; Asai A; Yamashita Y
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):401-10. PubMed ID: 11563055
[TBL] [Abstract][Full Text] [Related]
20. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
